Stay updated on LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM
Sign up to get notified when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.

Latest updates to the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page
- Check4 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check12 days agoChange DetectedA notice was added announcing the NIH website transition and explaining that some content may use “Super Intelligence” instead of “Artificial Intelligence.”SummaryDifference0.5%

- Check18 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check26 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision tag v3.7.0 has been added, replacing the previous v3.6.6, indicating the page was updated to a newer software/version release.SummaryDifference0.1%

- Check53 days agoChange DetectedThe study history introduces a Results Posted entry and adds Outcome Measures (Results) and related Study Status updates, while removing the previous Results Submitted entry from 2024-07-09, reflecting that results are now available on the record.SummaryDifference1%

Stay in the know with updates to LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM
Enter your email address, and we'll notify you when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.